Advertisement
U.S. markets open in 5 hours 20 minutes

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
121.44-0.08 (-0.07%)
At close: 04:01PM EDT
121.76 +0.32 (+0.26%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close121.52
Open121.85
Bid0.00 x 1100
Ask0.00 x 800
Day's Range121.12 - 122.51
52 Week Range99.14 - 130.24
Volume7,851,996
Avg. Volume8,328,478
Market Cap307.564B
Beta (5Y Monthly)0.38
PE Ratio (TTM)809.60
EPS (TTM)0.15
Earnings DateApr 25, 2024
Forward Dividend & Yield3.08 (2.54%)
Ex-Dividend DateMar 14, 2024
1y Target Est123.22
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Merck & Company, Inc.
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    21 hours agoArgus Research
View more
  • Simply Wall St.

    Insiders At Merck Sold US$15m In Stock, Alluding To Potential Weakness

    Many Merck & Co., Inc. ( NYSE:MRK ) insiders ditched their stock over the past year, which may be of interest to the...

  • PR Newswire

    FarmSee Ltd Announces the Completion of a Minority Investment in its Swine Monitoring Platform

    FarmSee, a pioneer in camera-based Artificial Intelligence ("AI") solutions for swine monitoring and production optimization, is excited to announce a strategic collaboration with MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK). MSD Animal Health, a biopharmaceuticals and technology solutions company, has participated in FarmSee's A round and has entered into a long-term agreement to integrate FarmSee's AI- based weighing technology into its global offerings for

  • Insider Monkey

    20 States with the Highest Cancer Rates

    In this article, we will be taking a look ta the 20 states with the highest cancer rates. If you do not want to learn about the global cancer market, head straight to the 5 States with the Highest Cancer Rates. States with the highest cancer rates like Florida, Texas, and New York, among others, […]